APO-OMEPRAZOLE 40 MG
OMEPRAZOLE : 40 MG · DIN 02245059 · APOTEX INC
Health Canada status: CANCELLED PRE MARKET
What is APO-OMEPRAZOLE?
APO-OMEPRAZOLE 40 MG contains OMEPRAZOLE : 40 MG. It is listed in the Health Canada Drug Product Database under DIN 02245059, held by APOTEX INC, supplied as CAPSULE (DELAYED RELEASE) for ORAL administration. Health Canada currently lists it as cancelled pre market, status dated 28-Jul-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is APO-OMEPRAZOLE called?
The same molecule, OMEPRAZOLE, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Omeprazole Sandoz | Latin | Australia |
| ACILOC | Latin | Bahrain, Saudi Arabia |
| Losec Tablets | Latin | Australia |
| Omepral | Latin | Australia, Morocco |
| Acimax Tablets | Latin | Australia |
| Maxor | Latin | Australia |
| Maxor EC Tabs | Latin | Australia |
| OMEPRAZOLE CAPS WGR | Latin | Australia |
| OMEPRAZOLE-WGR | Latin | Australia |
| Ozmep | Latin | Australia |
| Probitor | Latin | Australia |
| IXOR | Latin | Morocco |
| KALEST | Latin | Morocco |
| OMEGEN | Latin | Morocco |
| OMEPRAZOLE OLIKLA | Latin | Czechia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02245059 |
|---|---|
| Brand name | APO-OMEPRAZOLE |
| Generic / active ingredient | OMEPRAZOLE : 40 MG |
| Manufacturer | APOTEX INC |
| Strength | 40 MG |
| Dosage form | CAPSULE (DELAYED RELEASE) |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | A02BC01 OMEPRAZOLE |
| AHFS class | 56:28.36 |
| Biosimilar | No |
| Health Canada status | CANCELLED PRE MARKET |
| Status date | 28-Jul-2021 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02245059 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2245059 |
| Brand name | APO-OMEPRAZOLE |
| Active ingredient / INN | OMEPRAZOLE : 40 MG |
| ATC code | A02BC01 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A02 |
| AHFS class | 56:28.36 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | APOTEX INC |
Which pack is which?
| Strength on the label | 40 MG |
|---|---|
| Dosage form | CAPSULE (DELAYED RELEASE) |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code A02BC01 OMEPRAZOLE. 12 of 57 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACH-OMEPRAZOLE | 20 MG | TABLET (DELAYED-RELEASE) | ACCORD HEALTHCARE INC | MARKETED | DIN 02416549 |
| APO-OMEPRAZOLE | 20 MG | CAPSULE (DELAYED RELEASE) | APOTEX INC | MARKETED | DIN 02245058 |
| BIO-OMEPRAZOLE | 20 MG | TABLET (DELAYED-RELEASE) | BIOMED PHARMA | MARKETED | DIN 02449927 |
| HEARTBURN CONTROL | 20 MG | CAPSULE (DELAYED RELEASE) | APOTEX INC | MARKETED | DIN 02435683 |
| JAMP-OMEPRAZOLE DR | 20 MG | TABLET (DELAYED-RELEASE) | JAMP PHARMA CORPORATION | MARKETED | DIN 02420198 |
| LOSEC | 20 MG | CAPSULE (DELAYED RELEASE) | CHEPLAPHARM ARZNEIMITTEL GMBH | MARKETED | DIN 00846503 |
| LOSEC MUPS | 20 MG | TABLET (DELAYED-RELEASE) | CHEPLAPHARM ARZNEIMITTEL GMBH | MARKETED | DIN 02242462 |
| OMEPRAZOLE | 20 MG | CAPSULE (DELAYED RELEASE) | PRO DOC LIMITEE | MARKETED | DIN 02339927 |
| OMEPRAZOLE | 20 MG | CAPSULE (DELAYED RELEASE) | SANIS HEALTH INC | MARKETED | DIN 02348691 |
| OMEPRAZOLE-20 | 20 MG | CAPSULE (DELAYED RELEASE) | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02411857 |
Who else supplies OMEPRAZOLE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. OMEPRAZOLE appears in 1096 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does OMEPRAZOLE cost around the world?
OMEPRAZOLE is listed on 12 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Australia | ex-manufacturer | 12 | 115 | AUD███.██ |
| Greece | producer price (ex-factory) | 92 | 92 | EUR███.██ |
| Morocco | PPV (public price) | 18 | 57 | MAD███.██ |
| Saudi Arabia | public | 41 | 56 | SAR███.██ |
| Bahrain | retail (max) | 24 | 48 | BHD███.██ |
| South Africa | single exit price | 33 | 41 | ZAR███.██ |
| Luxembourg | reimbursement | 32 | 32 | EUR███.██ |
| Austria | KVP (Kassenverkaufspreis) | 19 | 31 | EUR███.██ |
| Czechia | max producer price (ex-factory) | 8 | 23 | CZK███.██ |
| United Arab Emirates | public | 11 | 17 | AED███.██ |
| United Kingdom | hospital | 8 | 8 | GBP███.██ |
| Iceland | max wholesale | 4 | 4 | ISK███.██ |
524 pack listings across 302 brand entries and 11 price bases, refreshed 08 Sep 2026. Ranges span every OMEPRAZOLE pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled pre market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.